Sinafo Medical Technology

The company's core offering is the DQ24, an all-in-one automated digital PCR (dPCR) system. This system is powered by the proprietary VibroJect® technology, a novel method for generating droplets that does not rely on traditional microfluidic chips. VibroJect® works by using a sophisticated syringe pump to control the flow of a reaction mixture through a micro-needle that vibrates at a constant frequency, steadily splitting the mixture into tens of thousands of uniform droplets. This automated process is designed to maximize sample utilization by minimizing dead volume. The resulting system offers an accessible and more affordable dPCR operation.

The DQ24 system is designed to be user-friendly, easy to install, and calibration-free. It is an open system, allowing for the flexible use of various master mixes, which simplifies the adaptation of Real-Time PCR optimizations to dPCR technology. The product has applications in oncology for detecting cancer biomarkers, cell and gene therapy, pathogen detection, and gene expression analysis. The system and its software are compliant with FDA and CE-IVD standards, ensuring data integrity for regulatory requirements. In addition to the DQ24 system, the company offers related consumables and the SAG-100 droplet workstation for applications like single-cell analysis and micro-organism screening.